Kartos Therapeutics Appoints Dr. Srdan Verstovsek as Chief Medical Officer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Kartos Therapeutics, Inc. (“Kartos” or the “Company”), a clinical stage biopharmaceutical company dedicated to the development of novel, targeted therapeutics that meaningfully improve the lives of patients with cancer, today announced that Dr. Srdan (Serge) Verstovsek, MD, PhD, has been named Chief Medical Officer (CMO). Dr. Verstovsek...
